Author:
Michel Martin C.,Ochodnicky Peter,Summers Roger J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference71 articles.
1. Aizawa N, Igawa Y, Nishizawa O, Wyndaele J-J (2010) Effects of CL316,243, a beta3-adrenoceptor agonist, and intravesical prostaglandin E2 on the primary bladder afferent activity of the rat. Neurourol Urodyn in press
2. Arch JRS (2008) Perspectives from β3-adrenoceptor agonists on pharmacology, physiology and obesity drug discovery. Naunyn-Schmiedeberg's Arch Pharmacol 378:225–240
3. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S (1984) Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163–165
4. Arner P, Kriegholm E, Engfeldt P (1991) In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue. J Pharmacol Exp Ther 259:317–323
5. Atef N, Lafontan M, Double A, Helary C, Ktorza A, Penicaud L (1996) A specific β3-adrenoceptor agonist induces pancreatic islet blood flow and insulin secretion in rats. Eur J Pharmacol 298:287–292
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献